Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Prazolamine** is an oral convenience co-pack from Physician Therapeutics containing 60 Theramine medical-food capsules and 30 carisoprodol 350 mg tablets. Theramine is a proprietary amino-acid and polyphenol-based medical food intended for dietary management of pain and inflammatory conditions, while carisoprodol is a centrally acting skeletal-muscle relaxant used for short-term relief of discomfort associated with acute, painful musculoskeletal conditions. The DailyMed label identifies Prazolamine as an unapproved drug product and states that its labeling has not been approved by FDA. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99265e39-af23-43eb-a552-305f0a218fdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prazolamine.